Analyst picks & changes
By BC Staff | Dec 18, 2006 | 8:00 AM GMT
Analyst picks & changes
| Company | Bank | Analyst | Coverage | Opinion | Wk chg | 12/15 cls |
| Anesiva (ANSV) | Rodman | Elemer Piros | New | Market outperform | 1% | $6.60 |
| Piros set a $9 target. He expects FDA to approve ANSV's NDA for Zingo to treat acute pain associated with venous access procedures in children in 4Q07 and believes the company will launch the product for children in 2008 and for adults in 2009. He estimates Zingo will achieve peak annual sales of about $150M in 2013. |
| Array (ARRY) | Oppenheimer | Cory Kasimov | New | Buy | -4% |
|
Read the full 887 word article
